The aim of the study was to analyze the results of stereotactic radiotherap
y using a linear accelerator in patients with brain metastases. We quantifi
ed the following clinical parameters: tumor response and tumor control afte
r therapy, survival, and side effects. Results of the treatment were compar
ed with those from traditional treatment strategies such as surgery and who
le brain irradiation. Sixty patients with brain metastases (80 lesions, 36
men and 24 women, mean age 57 years) were treated with stereotactic radioth
erapy. The mean follow-up time was 13 months.
Conclusion: Stereotactic radiotherapy is an important option in the treatme
nt strategy for patients with brain metastases. In comparison to whole brai
n irradiation, stereotactic radiotherapy achieved a higher local tumor cont
rol with a lower rate of side effects. In comparison to surgery, stereotact
ic radiotherapy has the advantages of shorter treatment time and lower trea
tment-related morbidity and mortality.